Technical Analysis for PVCTW - Provectus Biopharmaceuticals Inc. Warrant

Grade Last Price % Change Price Change
grade D 0.0064 -14.67% -0.0011
PVCTW closed down 14.67 percent on Thursday, January 16, 2020, on 1.61 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical PVCTW trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -14.67%
Narrow Range Bar Range Contraction -14.67%
Wide Bands Range Expansion -14.67%
Down 3 Days in a Row Weakness -14.67%
Gapped Down Weakness -14.67%
Older signals for PVCTW ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com or contact Porter, LeVay & Rose, Inc.
Medicine Medical Specialties RTT Organ Systems Immunotherapy Autoimmune Diseases Breast Cancer Psoriasis Atopic Dermatitis Fda Melanoma Biopharmaceuticals Dermatitis Metastatic Melanoma Hepatocellular Carcinoma Liver Cancer Solid Tumor Cancers Skin Cancer National Institute Of Health

Is PVCTW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.089
52 Week Low 0.0029
Average Volume 38,809
200-Day Moving Average 0.0140
50-Day Moving Average 0.0091
20-Day Moving Average 0.0095
10-Day Moving Average 0.0093
Average True Range 0.0032
ADX 13.03
+DI 29.4248
-DI 45.3540
Chandelier Exit (Long, 3 ATRs ) 0.0094
Chandelier Exit (Short, 3 ATRs ) 0.0129
Upper Bollinger Band 0.0161
Lower Bollinger Band 0.0029
Percent B (%b) 0.27
BandWidth 138.9474
MACD Line 0.0001
MACD Signal Line 0.0003
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0081
Resistance 3 (R3) 0.0079 0.0073 0.0078
Resistance 2 (R2) 0.0073 0.0068 0.0073 0.0077
Resistance 1 (R1) 0.0068 0.0066 0.0071 0.0070 0.0076
Pivot Point 0.0062 0.0062 0.0063 0.0062 0.0062
Support 1 (S1) 0.0057 0.0057 0.0060 0.0059 0.0052
Support 2 (S2) 0.0051 0.0055 0.0051 0.0051
Support 3 (S3) 0.0046 0.0051 0.0050
Support 4 (S4) 0.0048